Evidence map›Paper›PMID 41217632›Full record

ArticleForensic science, medicine, and pathology2025

The time frame of third molar mineralization in a northern chinese population.

Julian Wirtz, Yu-Cheng Guo, Maximilian Timme, Sven Schmidt, Andreas Schmeling

Abstract read
PubMed Publisher
In one paragraph

Article in Forensic science, medicine, and pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Julian WirtzInstitute of Legal Medicine, University and University Hospital Münster, Röntgenstraße 23, Münster, 48149, Germany.ORCID http://orcid.org/0009-0005-1406-785X
Yu-Cheng GuoDepartment of Orthodontics, Stomatological Hospital of Xi'an Jiaotong University, 98 XiWu Road, Xi'an, Shaanxi, 710004, People's Republic of China.ORCID http://orcid.org/0000-0002-5820-2444
Maximilian TimmeInstitute of Legal Medicine, University and University Hospital Münster, Röntgenstraße 23, Münster, 48149, Germany. m.timme@uni-muenster.de.ORCID http://orcid.org/0000-0002-7717-3378
Sven SchmidtInstitute of Legal Medicine, University and University Hospital Münster, Röntgenstraße 23, Münster, 48149, Germany.
Andreas SchmelingInstitute of Legal Medicine, University and University Hospital Münster, Röntgenstraße 23, Münster, 48149, Germany.ORCID http://orcid.org/0000-0002-0135-1617

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A key criterion in dental age determination is the assessment of third molar mineralization. The objective of this study was to provide reference data for Demirjian stages D-H of teeth 38 and 48 in a northern Chinese population. To this end, 988 digital orthopantomograms (OPGs) of northern Chinese individuals aged 12-26 years were examined. Of the total sample, 822 OPGs showed at least one evaluable lower third molar. The mean ages for both teeth in males are above 18 years from stage G onwards. In females, the mean ages for both teeth are above 18 years from stage F onwards. The youngest individuals with mineralization stage H were older than 18.0 years in both sexes. Since studies with larger case numbers have also reported minimum ages for this stage below the age of 18, the minimum ages for stage H presented in this study cannot be recommended for age assessment practice. In order to avoid stage misclassifications, which are particularly problematic when applying the minimum age principle, stage classifications in future studies should be made consensually by experienced examiners.

Indexed as

Demirjian stagesDental ageMineralizationOPGThird molar

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.